USANA Health Sciences Inc... (USNA)
NYSE: USNA
· Real-Time Price · USD
28.53
0.24 (0.85%)
At close: Sep 26, 2025, 3:59 PM
28.53
0.00%
After-hours: Sep 26, 2025, 06:26 PM EDT
USANA Health Sciences Revenue Breakdown
| Period Ending | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 |
|---|---|---|---|---|---|---|---|---|---|
| All Other Revenue | 2M | 3.34M | 1.75M | 1.66M | 1.65M | 1.48M | 1.43M | 1.41M | 1.48M |
| All Other Revenue Growth | -40.14% | +90.31% | +5.60% | +0.54% | +11.70% | +3.21% | +1.85% | -4.93% | n/a |
| Direct Selling Revenue | 210.45M | 421.17M | 198.47M | 211.21M | 226.15M | 219.6M | 211.93M | 236.79M | 246.88M |
| Direct Selling Revenue Growth | -50.03% | +112.21% | -6.03% | -6.61% | +2.98% | +3.62% | -10.50% | -4.08% | n/a |
Revenue by Geography
| Period Ending | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas And Europe Revenue | 76.13M | 337.81M | 40.15M | 42.24M | 42.7M | 177.1M | 43.36M | 44.59M | 48.65M | 183.43M | 50.64M |
| Americas And Europe Revenue Growth | -77.46% | +741.34% | -4.95% | -1.07% | -75.89% | +308.44% | -2.75% | -8.34% | -73.48% | +262.20% | n/a |
| Asia Pacific Revenue | 173.41M | 228.1M | 160.07M | 170.63M | 185.1M | 115.92M | 170M | 193.62M | 199.71M | 118.29M | 182.66M |
| Asia Pacific Revenue Growth | -23.98% | +42.50% | -6.19% | -7.82% | +59.68% | -31.81% | -12.19% | -3.05% | +68.83% | -35.24% | n/a |
| China Revenue | 107.69M | 36.25M | 91.28M | 105.11M | 115.75M | 22.07M | 94.67M | 117.88M | 110.03M | 24.54M | 97.44M |
| China Revenue Growth | +197.06% | -60.28% | -13.16% | -9.19% | +424.60% | -76.69% | -19.69% | +7.13% | +348.33% | -74.81% | n/a |
| Greater China Revenue | 118.75M | 73.46M | 102.26M | 115.51M | 127.61M | 39.12M | 106.61M | 128.75M | 123.82M | 40.6M | 109.68M |
| Greater China Revenue Growth | +61.64% | -28.16% | -11.47% | -9.48% | +226.25% | -63.31% | -17.20% | +3.98% | +204.99% | -62.99% | n/a |
| North Asia Revenue | 18.94M | n/a | 20.54M | 19.71M | 21.42M | n/a | 24.24M | 25.53M | 29.61M | n/a | 25.67M |
| North Asia Revenue Growth | n/a | n/a | +4.22% | -7.99% | n/a | n/a | -5.03% | -13.78% | n/a | n/a | n/a |
| Southeast Asia Pacific Revenue | 35.72M | n/a | 37.27M | 35.4M | 36.06M | n/a | 39.15M | 39.34M | 46.29M | n/a | 47.31M |
| Southeast Asia Pacific Revenue Growth | n/a | n/a | +5.27% | -1.84% | n/a | n/a | -0.47% | -15.01% | n/a | n/a | n/a |
| United States Revenue | 57.92M | n/a | 21.46M | 21.64M | 22.16M | n/a | 22.98M | 23.68M | 25.98M | n/a | 26.94M |
| United States Revenue Growth | n/a | n/a | -0.82% | -2.36% | n/a | n/a | -2.96% | -8.87% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 29, 2025 | Dec 28, 2024 | Sep 28, 2024 | Jun 29, 2024 | Mar 30, 2024 | Dec 30, 2023 | Sep 30, 2023 | Jul 1, 2023 | Apr 1, 2023 | Dec 31, 2022 | Oct 1, 2022 | Jul 2, 2022 | Apr 2, 2022 | Jan 1, 2022 | Oct 2, 2021 | Jul 3, 2021 | Apr 3, 2021 | Jan 2, 2021 | Sep 26, 2020 | Jun 27, 2020 | Mar 28, 2020 | Dec 28, 2019 | Sep 28, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 29, 2018 | Sep 29, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 30, 2017 | Sep 30, 2017 | Jul 1, 2017 | Apr 1, 2017 | Dec 31, 2016 | Oct 1, 2016 | Jul 2, 2016 | Apr 2, 2016 | Jan 2, 2016 | Oct 3, 2015 | Jul 4, 2015 | Apr 4, 2015 | Jan 3, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 168.95M | 91.44M | 73.35M | 61.3M | 150.88M | 160.06M | 154.54M | 153.23M | 170.48M | 173M | 158.98M | 164.11M | 185.59M | 188.42M | 183.28M | 182.87M | 226.1M | 206.13M | 198.96M | 196.8M | 171.73M | 181.55M | 179.44M | 177.32M | 178.37M | 192.09M | 200.99M | 199.38M | 200.33M | 199.49M | 191.51M | 183.27M | 180.79M | 179.78M | 174.74M | 173.41M | 175.09M | 164.03M | 157.27M | 154.28M | 154.38M | 151.23M | 157.72M |
| Selling, General, and Administrative Revenue Growth | +84.77% | +24.66% | +19.66% | -59.38% | -5.73% | +3.57% | +0.86% | -10.12% | -1.46% | +8.82% | -3.13% | -11.57% | -1.50% | +2.81% | +0.22% | -19.12% | +9.69% | +3.60% | +1.10% | +14.60% | -5.41% | +1.18% | +1.19% | -0.59% | -7.14% | -4.43% | +0.81% | -0.47% | +0.42% | +4.17% | +4.49% | +1.37% | +0.56% | +2.88% | +0.77% | -0.96% | +6.75% | +4.30% | +1.94% | -0.07% | +2.09% | -4.11% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.56M | n/a | n/a | n/a | 11.11M | n/a | n/a | n/a | 10.63M | n/a | n/a | n/a | 10.26M | n/a | n/a | n/a | 10.24M | n/a | n/a | n/a | 8.95M | n/a | n/a | n/a | 8.84M | n/a | n/a | n/a | 6.42M | n/a | n/a | n/a | 5.13M |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a |